Mangoceuticals, Inc.
MGRX
$1.71
$0.031.79%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.84M | -1.95M | -2.00M | -2.39M | -2.37M |
| Total Depreciation and Amortization | 415.00K | 721.80K | 300.00 | 3.20K | 6.20K |
| Total Amortization of Deferred Charges | -- | -464.30K | 241.60K | 222.70K | -- |
| Total Other Non-Cash Items | 1.99M | 507.20K | 611.50K | 877.40K | 454.40K |
| Change in Net Operating Assets | 160.20K | 54.10K | -20.00K | -289.60K | 915.80K |
| Cash from Operations | -2.27M | -1.13M | -1.17M | -1.58M | -991.10K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 65.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 0.00 | 0.00 | 65.00K | -- |
| Total Debt Issued | -- | -37.50K | 0.00 | 100.00K | 87.50K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.14M | 760.00K | 0.00 | 388.30K | 180.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 1.15M | 400.00K | 750.00K | 1.50M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.29M | 1.12M | 750.00K | 1.99M | 267.50K |
| Foreign Exchange rate Adjustments | 7.60K | -8.20K | -500.00 | -1.10K | -100.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 17.80K | -15.30K | -416.30K | 474.90K | -723.70K |